1. Home
  2. AMPH vs RXST Comparison

AMPH vs RXST Comparison

Compare AMPH & RXST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMPH
  • RXST
  • Stock Information
  • Founded
  • AMPH 1996
  • RXST 1997
  • Country
  • AMPH United States
  • RXST United States
  • Employees
  • AMPH N/A
  • RXST N/A
  • Industry
  • AMPH Biotechnology: Pharmaceutical Preparations
  • RXST Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • AMPH Health Care
  • RXST Health Care
  • Exchange
  • AMPH Nasdaq
  • RXST Nasdaq
  • Market Cap
  • AMPH 1.1B
  • RXST 553.1M
  • IPO Year
  • AMPH 2014
  • RXST 2021
  • Fundamental
  • Price
  • AMPH $21.70
  • RXST $8.03
  • Analyst Decision
  • AMPH Hold
  • RXST Hold
  • Analyst Count
  • AMPH 5
  • RXST 11
  • Target Price
  • AMPH $38.00
  • RXST $19.40
  • AVG Volume (30 Days)
  • AMPH 488.2K
  • RXST 1.7M
  • Earning Date
  • AMPH 08-06-2025
  • RXST 08-07-2025
  • Dividend Yield
  • AMPH N/A
  • RXST N/A
  • EPS Growth
  • AMPH N/A
  • RXST N/A
  • EPS
  • AMPH 2.77
  • RXST N/A
  • Revenue
  • AMPH $730,659,000.00
  • RXST $148,310,000.00
  • Revenue This Year
  • AMPH $0.67
  • RXST $22.16
  • Revenue Next Year
  • AMPH $5.18
  • RXST $20.91
  • P/E Ratio
  • AMPH $8.03
  • RXST N/A
  • Revenue Growth
  • AMPH 8.05
  • RXST 46.70
  • 52 Week Low
  • AMPH $21.48
  • RXST $6.32
  • 52 Week High
  • AMPH $53.96
  • RXST $58.23
  • Technical
  • Relative Strength Index (RSI)
  • AMPH 28.01
  • RXST 21.66
  • Support Level
  • AMPH $22.81
  • RXST $6.32
  • Resistance Level
  • AMPH $23.77
  • RXST $8.50
  • Average True Range (ATR)
  • AMPH 0.76
  • RXST 0.77
  • MACD
  • AMPH -0.20
  • RXST -0.52
  • Stochastic Oscillator
  • AMPH 9.27
  • RXST 21.50

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

About RXST RxSight Inc.

RxSight Inc is a commercial-stage medical technology company dedicated towards improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture and sale of light adjustable lenses and related capital equipment.

Share on Social Networks: